Table 2.
Comparison of patients’ background between left gastric vein (LGV) and non-LGV groups.
| □ | LGV Group | Non-LGV Group | * p-Value |
|---|---|---|---|
| Number | 37 | 13 | □ |
| Age (years) | 66.8 ± 10.2 | 68.8 ± 7.5 | 0.69 |
| Gender (male/female) | 12/25 | 6/7 | 0.50 |
| WBC (×10/mm3) | 467 ± 232 | 426 ± 132 | 0.98 |
| Hemoglobin (g/dL) | 12.4 ± 6.2 | 11.2 ± 2.0 | 0.53 |
| Platelet counts (×104/mm3) | 9.1 ± 3.7 | 11.6 ± 5.1 | 0.13 |
| AST (IU/L) | 63.8 ± 43.6 | 43.4 ± 14.5 | 0.17 |
| ALT (IU/L) | 46.9 ± 38.6 | 29.4 ± 38.56 | 0.11 |
| Total bilirubin (mg/dL) | 1.24 ± 0.85 | 0.95 ± 0.30 | 0.41 |
| Total protein (g/dL) | 7.00 ± 0.58 | 6.88 ± 0.77 | 0.65 |
| Albumin (g/dL) | 3.40 ± 0.76 | 3.48 ± 0.56 | 0.30 |
| Creatinine (mg/dL) | 0.7 ± 0.2 | 0.6 ± 0.2 | 0.80 |
| eGFR (mL/min/1.73 m2) | 80.1 ± 22.8 | 81.5 ± 23.9 | 0.89 |
| Prothrombin time (%) | 83.0 ± 13.8 | 84.3 ± 14.2 | 0.64 |
| Total cholesterol (IU/L) | 151.4 ± 39.8 | 138.8 ± 27.2 | 0.21 |
| Blood glucose (mg/dL) | 131.9 ± 46.0 | 126.4 ± 34.8 | 0.82 |
| NH3 (μg/dL) | 75.3 ± 34.0 | 74.3 ± 41.0 | 0.66 |
| Child-Pugh A/B/C | 27/10/0 | 12/1/0 | 0.24 |
| HCC (±) | 20/17 | 7/6 | 1.0 |
| GV form F1/2/3 | 1/12/24 | 1/5/7 | 0.62 |
| EV form F0/1/2/3 | 23/11/2/1 | 7/6/0/0 | 0.72 |
| Etiology (HBV/HCV/NBNC/Alcohol) | 1/22/4/10 | 2/6/3/2 | 0.17 |
| Esophagus varices exacerbation | 26/37 | 4/13 | 0.02 |
| Mean periods from BRTO to esophageal varices exacerbation (months) |
17.6 ± 17.0 | 27.2 ± 17.3 | 0.06 |
| Mean observation periods (months) | 37.73 ± 28.83 | 29.14 ± 26.67 | 0.32 |
Data are expressed as the mean ± standard deviation. * p-value, comparison between two groups, by univariate analysis; WBC—white blood cell counts; AST—aspartate aminotransferase; ALT—alanine aminotransferase; eGFR—estimated glomerular filtration rate; HCC—hepatocellular carcinoma; GV—gastric varices; EV—esophageal varices; HBV—hepatitis B virus; HCV—hepatitis C virus; NBNC—non-HBV, non-HCV; LGV—left gastric vein.